PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,184 | -15.6% | 122,892 | +13.3% | 0.01% | -20.0% |
| Q2 2023 | $382,801 | +23.8% | 108,448 | +8.4% | 0.02% | +15.4% |
| Q1 2023 | $309,204 | -17.2% | 100,072 | +13.3% | 0.01% | -31.6% |
| Q4 2022 | $373,602 | +91.6% | 88,322 | +7.4% | 0.02% | +90.0% |
| Q3 2022 | $195,000 | -6.7% | 82,247 | +12.0% | 0.01% | -9.1% |
| Q2 2022 | $209,000 | +21.5% | 73,424 | +23.0% | 0.01% | +57.1% |
| Q1 2022 | $172,000 | +56.4% | 59,680 | +65.6% | 0.01% | +40.0% |
| Q4 2021 | $110,000 | -55.6% | 36,032 | +1.9% | 0.01% | -58.3% |
| Q3 2021 | $248,000 | +5.1% | 35,360 | +37.3% | 0.01% | 0.0% |
| Q2 2021 | $236,000 | +11.3% | 25,745 | +18.3% | 0.01% | -7.7% |
| Q1 2021 | $212,000 | +9.8% | 21,768 | +15.6% | 0.01% | 0.0% |
| Q4 2020 | $193,000 | +52.0% | 18,828 | +54.5% | 0.01% | +18.2% |
| Q2 2020 | $127,000 | – | 12,186 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |